The pharmacology of bipolar disorder during pregnancy and breastfeeding

Expert Opinion on Drug Safety

Volumn 3, Issue 3, 2004, Pages 221-229

  Dodd, Seetal ^a   Berk, Michael ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bipolar disorder; Breastfeeding; Mood stabilizers; Pregnancy; Teratogenicity

Indexed keywords

10,11 DIHYDRO 10,11 DIHYDROXYCARBAMAZEPINE; ADRENERGIC RECEPTOR AFFECTING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BUSPIRONE; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; FOLIC ACID; LAMOTRIGINE; LICARBAZEPINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PHENOTHIAZINE; QUETIAPINE; RISPERIDONE; SELENIUM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

BIPOLAR DISORDER; BREAST FEEDING; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG MILK LEVEL; FEMALE; HUMAN; HYPOFIBRINOGENEMIA; INDIVIDUALIZATION; NEURAL TUBE DEFECT; PREGNANCY DISORDER; PSYCHOPHARMACOLOGY; RECURRENT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SPINA BIFIDA; TREATMENT PLANNING;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BREAST FEEDING; FEMALE; HUMANS; LITHIUM COMPOUNDS; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS;

EID: 2942695913     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.3.3.221     Document Type: Review

References (99)

1. VIGUERA AC, COHEN LS: The course and management of bipolar disorder during pregnancy. Psychopharmacol. Bull. (1998) 34:339-346.
2. FINNERTY M, LEVIN Z, MILLER LJ: Acute manic episodes in pregnancy. Am. J. Psychiatry (1996) 153:261-263.
3. GROF P, ROBBINS W, ALDA M et al.: Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J. Affect. Disord. (2000) 61:31-39.
4. VIGUERA AC, NONACS R, COHEN LS et al.: Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am. J. Psychiatry (2000) 157:179-184.
5. BRATFOS O, HAUG JO: Puerperal mental disorders in manic-depressive females. Acta Psychiatr. Scand. (1966) 42:285-294.
6. REICH T, WINOKUR G: Postpartum psychoses in patients with manic depressive disease. J. herv. Ment. Dis. (1970) 151:60-68.
7. VIGUERA AC, COHEN LS, BALDESSARINI RJ, NONACS R: Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can. J. Psychiatry (2002) 47:426-436.
8. KENDELL RE, CHALMERS JC, PLATZ C: Epidemiology of puerperal psychoses. Br. J. Psychiatry (1987) 150:662-673.
9. FREEMAN MP, SMITH KW, FREEMAN SA et al.: The impact of reproductive events on the course of bipolar disorder in women. J. Clin. Psychiatry (2002) 63:284-287.
10. FREEMAN MP, KECK PE Jr, MCELROY SL: Postpartum depression with bipolar disorder. Am. J. Psychiatry (2001) 158:652.
11. CRUIKSHANK DP, WIGTON TR, HAYS PM: Maternal Physiology in Pregnancy. In: Obstetrics: normal and problem pregnancies. Gabbe SG, Niebyl JR, Simpson JL (Eds), Churchill Livingstone, Inc., New York (1996).
12. NEWPORT DJ, WILCOX MM, STOWE ZN: Maternal depression: a child's first adverse life event. Semin. Clin. Neuropsychiatry (2002) 7:113-119.
13. HAY DF, PAWLBY S, SHARP D et al.: Intellectual problems shown by 11-year-old children whose mothers had postnatal depression. J. Child Psychol. Psychiatry (2001) 42:871-889.
14. KURSTJENS S, WOLKE D: Effects of maternal depression on cognitive development of children over the first 7 years of life. J. Child Psychol. Psychiatry (2001) 42:623-636.
15. MURRAY L, COOPER P: Effects of postnatal depression on infant development. Arch. Dis. Child. (1997) 77:99-101.
16. UAUY R, DE ANDRACA I: Human milk and breast feeding for optimal mental development. J. Nutr. (1995) 125:S2278-S2280.
17. MARKOVITZ PJ, CALABRESE JR: Use of anticonvulsants for manic depression during pregnancy. Psychosomatics (1990) 31:118.
18. SCHOU M, GOLDFIELD MD, WEINSTEIN MR, VILLENEUVE A: Lithium and pregnancy. I. Report from the Register of Lithium Babies. Br. Med. J. (1973) 2:135-136.
19. COHEN LS, FRIEDMAN JM, JEFFERSON JW, JOHNSON EM, WEINER ML: A reevaluation of risk of in utero exposure to lithium. JAMA (1994) 271:146-150.
20. ERNST CL, GOLDBERG JF: The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J. Clin. Psychiatry (2002) 63(Suppl. 4):42-55.
21. FRASSETTO F, TOURNEUR MARTEL F, BARJHOUX CE, VILLIER C, BOT BL, VINCENT F: Goiter in a newborn exposed to lithium in utero. Ann. Pharmacother. (2002) 36:1745-1748.
22. IQBAL MM, SOHHAN T, MAHMUD SZ: The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation. J. Toxicol. Clin. Toxicol. (2001) 39:381-392.
23. IQBAL MM, GUNDLAPALLI SP, RYAN WG, RYALS T, PASSMAN TE: Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South. Med. J. (2001) 94:304-322.
24. JACOBSON SJ, JONES K, JOHNSON K et al.: Prospective multi-centre study of pregnancy outcome after lithium exposure during first trimester. Lancet (1992) 339:530-533.
25. KALLEN B, TANDBERG A: Lithium and pregnancy. A cohort study on manic-depressive women. Acta Psychiatr. Scand. (1983) 68:134-139.
26. ARNON RG, MARIN-GARCIA J, PEEDEN JN: Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant. Am. J. Dis. Child. (1981) 135:941-943.
27. WILSON N, FORFAR JD, GODMAN MJ: Atrial flutter in the newborn resulting from maternal lithium ingestion. Arch. Dis. Child. (1983) 58:538-539.
28. KARLSSON K, LINDSTEDT G, LUNDBERG PA, SELSTAM U: Letter: Transplacental lithium poisoning: reversible inhibition of fetal thyroid. Lancet (1975) 1:1295.
29. MIZRAHI EM, HOBBS JF, GOLDSMITH DI: Nephrogenic diabetes insipidus in transplacental lithium intoxication. J. Pediatr. (1979) 94:493-495.
30. PINELLI JM, SYMINGTON AJ, CUNNINGHAM KA, PAES BA: Case report and review of the perinatal implications of maternal lithium use. Am. J. Obstet. Gynecol. (2002) 187:245-249.
31. MORRELL P, SUTHERLAND GR, BUAMAH PK, OO M, BAIN HH: Lithium toxicity in a neonate. Arch. Dis. Child. (1983) 58:539-541.
32. YODER MC, BELIK J, LANNON RA, PEREIRA GR: Infants of mothers treated with lithium during pregnancy have an increased incidence of prematurity, macrosomia and perinatal mortality. Pediatr. Res. (1984) 18:163A.
33. WOODY JN, LONDON WL, WILBANKS GD Jr: Lithium toxicity in a newborn. Pediatrics (1971) 47:94-96.
34. LLEWELLYN A, STOWE ZN, STRADER JR Jr: The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J. Clin. Psychiatry (1998) 59 (Suppl. 6):57-64. Discussion 65.
35. KRAMER A, KNOPPERT-VAN DER KLEIN EAM, VAN KAMP IL et al.: Bipolar and pregnant? No problem! A clinical evaluation of lithium use during pregnancy. Eur. Neuropsychopharmacol. (2003) 13:S246.
36. WILLIAMS K, OKE S: Lithium and pregnancy. Psychiatr. Bull. (2000) 24:229-231.
37. LICHT RW, VESTERGAARD P, KESSING LV, LARSEN JK, THOMSEN PH: Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr. Scand. Suppl. (2003) 419:1-22.
38. SCHOU M, AMDISEN A: Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment. Br. Med. J. (1973) 2:138.
39. SCHOU M, AMDISEN A, STEENSTRUP OR: Lithium and pregnancy. II. Hazards to women given lithium during pregnancy and delivery Br. Med. J. (1973) 2:137-138.
40. WEINBAUM PJ, CASSIDY SB, VINTZILEOS Am. et al.: Prenatal detection of a neural tube defect after fetal exposure to valproic acid. Obstet. Gynecol. (1986) 67:S31-S33.
41. ROBERT E, GUIBAUD P: Maternal valproic acid and congenital neural tube defects. Lancet (1982) 2:937.
42. LINDHOUT D, MEINARDI H: Spina bifida and in utero exposure to valproate. Lancet (1984) 2:396.
43. PIPPENGER CE: Pharmacology of neural tube defects. Epilepsia (2003) 44(Suppl. 3):24-32.
44. KAO J, BROWN NA, SCHMID B, GOULDING EH, FABRO S: Teratogenicity of valproic acid: in vivo and in vitro investigations. Teratog. Carcinog. Mutagen. (1981) 1:367-382.
45. MAST TJ, CUKIERSKI MA, NAU H, HENDRICKX AG: Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model. Toxicology (1986) 39:111-119.
46. KOCH S, JAGER-ROMAN E, RATING D, HELGE H: Possible teratogenic effect of valproate during pregnancy. J. Pediatr. (1983) 103:1007-1008.
47. MCMAHON CL, BRADDOCK SR: Septo-optic dysplasia in a child exposed to valproic acid in utero. Teratology (1998) 57:284.
48. THISTED E, EBBESEN F: Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch. Dis. Child. (1993) 69:288-291.
49. WINTER RM, DONNAI D, BURN J, TUCKER SM: Fetal valproate syndrome: is there a recognisable phenotype? J. Med. Genet. (1987) 24:692-695.
50. DILIBERTI JH, FARNDON PA, DENNIS NR, CURRY CJ: The fetal valproate syndrome. Am. J. Med. Genet. (1984) 19:473-481.
51. ARDINGER HH, ATKIN JF, BLACKSTON RD et al.: Verification of the fetal valproate syndrome phenotype. Am. J. Med. Genet. (1988) 29:171-185.
52. RODRIGUEZ-PINILLA E, ARROYO I, FONDEVILLA J, GARCIA MJ, MARTINEZ-FRIAS ML: Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. Am. J. Med. Genet. (2000) 90:376-381.
53. BASON L, MING JE, ZACKAL EH: Intrauterine hemorrhage associated with prenatal valproate exposure, Am. J. Hum. Genet. (1998) 63:A159.
54. MAJER RV, GREEN PJ: Neonatal afibrinogenaemia due to sodium valproate. Lancet (1987) 2:740-741.
55. LEGIUS E, JAEKEN J, EGGERMONT E: Sodium valproate, pregnancy, and infantile fatal liver failure. Lancet (1987) 2:1518-1519.
56. STAHL MM, NEIDERUD J, VINCE E: Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J. Pediatr. (1997) 130:1001-1003.
57. TSURU N, MAEDA T, TSURUOKA M: Three cases of delivery under sodium valproate-placental transfer, milk transfer and probable teratogenicity of sodium valproate. Jpn. J. Psychiatry Neurol. (1988) 42:89-96.
58. CHAUDRON LH, JEFFERSON JW: Mood stabilizers during breastfeeding: a review. J. Clin. Psychiatry (2000) 61:79-90.
59. PIONTEK CM, BAAB S, PEINDL KS, WISNER KL: Serum valproate levels in 6 breastfeeding mother-infant pairs. J. Clin. Psychiatry (2000) 61:170-172.
60. IQBAL MM: Prevention of neural tube defects by periconceptional use of folic acid. Pediatr. Rev. (2000) 21:58-66; quiz 66.
61. FREY L, HAUSER WA: Epidemiology of neural tube defects. Epilepsia (2003) 44(Suppl. 3):4-13.
62. YERBY MS: Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia (2003) 44(Suppl. 3):33-40.
63. KAAJA E, KAAJA R, MATILA R, HIILESMAA V: Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology (2002) 58:549-553.
64. BAPTISTA T, ARAUJO H, RADA P, HERNANDEZ L: Congenital neuroblastoma in a boy born to a woman with bipolar disorder treated with carbamazepine during pregnancy. Prog. Neuropsychopharmacol. Biol. Psychiatry (1998) 22:445-454.
65. FREY B, SCHUBIGER G, MUSY JP: Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur. J. Pediatr. (1990) 150:136-138.
66. MERLOB P, MOR N, LITWIN A: Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann. Pharmacother. (1992) 26:1563-1565.
67. LINDHOUT D, HOPPENER RJ, MEINARDI H: Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia (1984) 25:77-83.
68. JONES KL, LACRO RV, JOHNSON KA, ADAMS J: Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl. J. Med. (1989) 320:1661-1666.
69. ROSA FW: Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med. (1991) 324:674-677.
70. LITTLE BB, SANTOS-RAMOS R, NEWELL JF, MABERRY MC: Megadose carbamazepine during the period of neural tube closure. Obstet. Gynecol. (1993) 82:705-708.
71. PYNNONEN S, KANTO J, SILLANPAA M, ERKKOLA R: Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol. Toxicol. (Copenh.) (1977) 41:244-253.
72. NIEBYL JR, BLAKE DA, FREEMAN JM, LUFF RD: Carbamazepine levels in pregnancy and lactation. Obstet. Gynecol. (1979) 53:139-140.
73. BRENT NB, WISNER KL: Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin. Pediatr. (Phila.) (1998) 37:41-44.
74. BERK M, DODD S: Recent developments in the treatment of bipolar disorders. Expert Opin. Investig. Drugs (2003) 12:1621-1632.
75. MORRELL MJ: The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Epilepsia (1996) 37(Suppl. 6):S34-S44.
76. RAMBECK B, KURLEMANN G, STODIECK SR, MAY TW, JURGENS U: Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur. J. Clin. Pharmacol. (1997) 51:481-484.
77. OHMAN I, VITOLS S, TOMSON T: Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia (2000) 41:709-713.
78. PENNELL PB: Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology (2003) 61:S35-S42.
79. MYLLYNEN P, PIENIMAKI P, JOUPPILA P, VAHAKANGAS K: Transplacental passage of oxcarbazepine and its metabolites in vivo. Epilepsia (2001) 42:1482-1485.
80. PIENIMAKI P, LAMPELA E, HAKKOLA J et al.: Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia (1997) 38:309-316.
81. MAY TW, KORN-MERKER E, RAMBECK B: Clinical pharmacokinetics of oxcarbazepine. Clin. Pharmacokinet. (2003) 42:1023-1042.
82. GUILLE C, SACHS GS, GHAEMI SN: A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J. Clin. Psychiatry (2000) 61:638-642.
83. KETTER TA, TOHEN M, VIETA E et al.: Open-label maintenance treatment for bipolar depression using olanzapine or olanzapine/fluoxetine combination. 43rd Annual NCDEU Conference. 27 - 30 May 2003, Boca Raton, Florida, USA (2003).
84. TOHEN M, VIETA E, CALABRESE JR et al.: Olanzapine/fluoxetine combination and olanzapine in the treatment of bipolar depression. American Psychiatric Association 156th Annual Meeting. 17 - 22 May 2003, San Francisco, USA (2003).
85. TOHEN M, SANGER TM, MCELROY SL et al.: Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry (1999) 156:702-709.
86. TOHEN M, BAKER RW, ALTSHULER LL et al.: Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry (2002) 159:1011-1017.
87. TOHEN M, BOWDEN CL, CALABRESE JR et al.: Olanzapine's efficacy for relapse prevention in bipolar disorder: a randomized double-blind, placebo-controlled 12-month clinical trial. Bipolar Disord. (2003) 5:89.
88. KECK PE Jr, VERSIANI M, POTKIN S et al.: Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry (2003) 160:741-748.
89. KECK PE Jr, MARCUS R, TOURKODIMITRIS S et al.: A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am. J. Psychiatry (2003) 160:1651-1658.
90. ADITYANJEE, SCHULZ SC: Clinical use of quetiapine in disease states other than schizophrenia. J. Clin. Psychiatry (2002) 63(suppl. 13):32-38.
91. PATTON SW, MISRI S, CORRAL MR, PERRY KF, KUAN AJ: Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can. J. Psychiatry (2002) 47:959-965.
92. GOLDSTEIN DJ, CORBIN LA, FUNG MC: Olanzapine-exposed pregnancies and lactation: early experience. J. Clin. Psychopharmacol. (2000) 20:399-403.
93. SCHENKER S, YANG Y, MATTIUZ E, TATUM D, LEE M: Olanzapine transfer by human placenta. Clin. Exp. Pharmacol. Physiol. (1999) 26:691-697.
94. GARDINER SJ, KRISTENSEN JH, BEGG EJ et al.: Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am. J. Psychiatry (2003) 160:1428-1431.
95. TENYI T, TRIXLER M, KERESZTES Z: Quetiapine and pregnancy. Am. J. Psychiatry (2002) 159:674.
96. NONACS R, COHEN LS: Assessment and treatment of depression during pregnancy: an update. Psychiatr. Clin. North Am. (2003) 26:547-562.
97. DODD S, BUIST A, NORMAN TR: Antidepressants and breast-feeding: a review of the literature. Paediatr. Drugs (2000) 2:183-192.
98. EINARSON A, FATOYE B, SARKAR M et al.: Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am. J. Psychiatry (2001) 158:1728-1730.
99. KULIN NA, PASTUSZAK A, SAGE SR et al.: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA (1998) 279:609-610.